BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 4219766)

  • 1. Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    Clin Exp Immunol; 1974 Apr; 16(4):575-81. PubMed ID: 4219766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of serum complement in the hypocomplementaemic nephritides.
    Williams DG; Peters DK; Fallows J; Petrie A; Kourilsky O; Morel-Maroger L; Cameron JS
    Clin Exp Immunol; 1974 Nov; 18(3):391-405. PubMed ID: 4219908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunopathology of the kidney in disseminated lupus erythematosus].
    Morel-Maroger L; Méry JP
    Pathol Biol (Paris); 1975 Jun; 23(6):492-3. PubMed ID: 1105354
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of complement in human nephritis.
    Lambert PH; Perrin LH; Mahieu P; Nydegger UE; Miescher PA
    Adv Nephrol Necker Hosp; 1974; 4():79-90. PubMed ID: 4220001
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glomerular localization of the early components of complement in glomerulonephritis].
    Barbiano di Belgiojoso G; Tarantino A; Durante A; Guerra L
    Minerva Nefrol; 1974; 21(3):169-78. PubMed ID: 4463297
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
    Kim Y; Vernier RL; Fish AJ; Michael AF
    Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement deposition in the kidney.
    Berger J
    Adv Nephrol Necker Hosp; 1974; 4():37-48. PubMed ID: 4219998
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoglobulin and complement deposits in lupus glomerulonephritis.
    Méry JP; Morel-Maroger L; Boelaert J
    Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtotal C4 deficiency and SLE-like disease.
    Irestedt M; Svensson A; Månsson T
    Acta Derm Venereol; 1986; 66(1):67-70. PubMed ID: 2424221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activation of the complement system in different forms of glomerulonephritis].
    Wegmüller E; Frey B; Hodler J
    Schweiz Med Wochenschr; 1977 Jul; 107(29):1028-34. PubMed ID: 331469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis.
    Roberts JL; Schwartz MM; Lewis EJ
    Clin Exp Immunol; 1978 Feb; 31(2):328-38. PubMed ID: 348363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K; Schur PH; Ruddy S
    Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of complement components in systemic lupus erythematosus by radial immunodiffusion.
    Finberg R; Barland P; Grayzel AI
    Am J Clin Pathol; 1977 Jan; 67(1):97-9. PubMed ID: 401557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of renal histological findings, serum C3, C4 level in patients with lupus nephritis by steroid therapy].
    Sueishi M; Tomioka H; Yanagisawa T; Nawata Y; Kagami M; Koike T; Takabayashi K; Yoshida S; Kumagai A; Tsuchida H
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):343-52. PubMed ID: 6471579
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus.
    Schrager MA; Rothfield NF
    J Clin Invest; 1976 Jan; 57(1):212-21. PubMed ID: 1245600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Components of the classical complement pathway in systemic lupus erythematosus].
    Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
    Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the second component of complement (C2) by electroimmunoassay in sera from patients with systemic lupus erythematosus.
    Ueda A; Kusaba T; Yanase T
    Clin Exp Immunol; 1983 Jul; 53(1):217-24. PubMed ID: 6409476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complement system proteins and hypocomplement glomerulopathy. Acute post-streptococcal glomerulonephritis, membranoproliferative glomerulonephritis, and glomerulonephritis in system lupus erythematosus].
    Popović-Rolović M; Maglajlić S; Radlović N
    Srp Arh Celok Lek; 1979 Nov; 107(11):629-44. PubMed ID: 552154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.